LENZ Therapeutics, Inc. (LENZ)

NASDAQ: LENZ · Real-Time Price · USD

16.98

-0.10 (-0.61%)

Dec 16, 2025, 9:58 AM EST - Market open

LENZ Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 16, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	531	794	-	-	-
Enterprise Value	333	578	-	-	-
Last Close Price	17.08	28.87	-	-	-
PB Ratio	2.52	3.89	-	-	-
P/TBV Ratio	2.76	3.89	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	-
Asset Turnover	0.08	-	-	0.46	-
Quick Ratio	12.46	20.09	3.55	4.68	14.61
Current Ratio	12.69	20.36	3.63	4.91	14.62
Return on Equity (ROE)	-28.78%	-38.94%	-157.61%	-39.80%	-
Return on Assets (ROA)	-19.52%	-25.64%	-77.17%	-20.07%	-
Return on Capital (ROIC)	-20.61%	-28.47%	-101.31%	-24.01%	-
Return on Capital Employed (ROCE)	-34.90%	-28.60%	-139.70%	-28.00%	-39.20%
Earnings Yield	-11.02%	-6.27%	-	-	-
FCF Yield	-8.64%	-7.54%	-	-	-
Buyback Yield / Dilution	-87.55%	-986.27%	79.28%	-1.05%	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q